- Home
- INDV vs GNW Comparison
INDV vs GNW Comparison
Compare INDV & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDV | GNW |
|---|---|---|
| Founded | N/A | 1871 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.6B |
| IPO Year | 2014 | 2004 |
Fundamental Metrics
Financial Performance| Metric | INDV | GNW |
|---|---|---|
| Price | $40.26 | $9.94 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | 1.5M | ★ 2.8M |
| Earning Date | 06-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 0.69 | 0.12 |
| Revenue | $1,239,000,000.00 | ★ $7,301,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $58.01 | $82.50 |
| Revenue Growth | ★ 4.29 | 0.08 |
| 52 Week Low | $17.10 | $7.61 |
| 52 Week High | $42.81 | $10.20 |
Technical Indicators
Market Signals| Indicator | INDV | GNW |
|---|---|---|
| Relative Strength Index (RSI) | 52.52 | 63.22 |
| Support Level | $38.47 | $8.01 |
| Resistance Level | $41.42 | $10.20 |
| Average True Range (ATR) | 1.24 | 0.22 |
| MACD | -0.16 | -0.01 |
| Stochastic Oscillator | 51.62 | 74.44 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has four main operating business segments: Enact, Closed Block segment, and Corporate and Other. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. The majority of the revenue is generated by the Enact segment. The company earns the maximum of its revenue in the United States.